Amedisys (AMED) EBITDA margin US GAAP (year values) |
|||||||||
2021 | 2022 | 2022 | 2023 | 2023 | LTM ? | CAGR 5 years ? | |||
EBITDA margin, % | ? | 14.5% | 8.25% | 9.33% | 9.70% | 9.70% | 7.92% | ||
Changes by years, y/y, % | +2pp | -6pp | +1pp | +0pp | 0pp | -2.1% |
Amedisys. EBITDA margin, %
Amedisys. EBITDA margin, changes, pp
Amedisys (AMED) EBITDA margin US GAAP (quarter values) |
||||||||
2024Q1 | 2023Q4 | 2024Q2 | 2024Q2 | 2024Q3 | LTM ? | |||
EBITDA margin, % | ? | 10.2% | 7.59% | 7.73% | 11.9% | 4.42% | 7.92% | |
Changes by years, y/y, % | +0pp | -4pp | -4pp | +0pp | -5pp | |||
Changes by quarters, q/q, % | +6pp | -3pp | +0pp | +4pp | -7pp |